Biology 12th Edition

Published by McGraw-Hill Education
ISBN 10: 0078024269
ISBN 13: 978-0-07802-426-9

Chapter 34 - Digestive Systems and Nutrition - Engage - Thinking Scientifically - Page 658: 3

Answer

See explanation

Work Step by Step

It is possible that the drug is undergoing biotransformation (metabolism) in the liver before entering the bloodstream. The liver is a major site of drug metabolism, where enzymes convert many drugs into metabolites that are more easily excreted from the body. The metabolites may have different molecular structures than the original drug, which could explain why the form of the drug collected from the blood is not the same as the form that was swallowed by the patient. Additionally, some drugs may be affected by pH changes as they pass through different parts of the digestive system. For example, the stomach has a very low pH that can break down some drugs, while the small intestine has a more neutral pH that may be better suited for drug absorption. It is possible that the drug for leukemia is stable in the neutral environment of the small intestine, but may be degraded or converted to a different form in the acidic environment of the stomach. Overall, the exact explanation for why the molecular form of the drug collected from the blood is not the same as the form that was swallowed by the patient may depend on the specific characteristics of the drug and how it interacts with different parts of the digestive and metabolic systems.
Update this answer!

You can help us out by revising, improving and updating this answer.

Update this answer

After you claim an answer you’ll have 24 hours to send in a draft. An editor will review the submission and either publish your submission or provide feedback.